Christan Itin (Autolus Therapeutics Ltd.)

Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc)

	Organisation	Autolus Therapeutics Ltd.
	Today	Autolus Therapeutics plc (Nasdaq: AUTL)
	Group	Autolus Therapeutics plc (Nasdaq: AUTL)
	Former/major organisation	Micromet AG
	Today	Amgen Research (Munich) GmbH
	Group	Amgen (Group)
	Product	T cell therapy
	Product 2	blinatumomab (AMG 103/MT103/MEDI-538)

Record changed: 2024-03-01

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Christan Itin

[1] BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London....
[2] Autolus Ltd.. (4/4/18). "Press Release: Autolus and Miltenyi Biotec Sign Strategic Supply Agreement". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)